{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:57:19Z","timestamp":1780732639546,"version":"3.54.1"},"reference-count":22,"publisher":"American Diabetes Association","issue":"7","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,7,1]]},"abstract":"<jats:p>OBJECTIVE\u2014Polycystic ovary syndrome (PCOS) is an insulin-resistant state with insulin resistance being an established therapeutic target; however, measurement of insulin resistance remains challenging. We aimed to 1) determine serum retinol-binding protein 4 (RBP4) levels (purported to reflect insulin resistance) in women with PCOS and control subjects, 2) examine the relationship of RBP4 to conventional markers of insulin resistance, and 3) examine RBP4 changes with interventions modulating insulin resistance in overweight women with PCOS.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014At baseline, 38 overweight women (BMI &amp;gt;27 kg\/m2) with PCOS and 17 weight-matched control subjects were compared. Women with PCOS were then randomly assigned to 6 months of a higher-dose oral contraceptive pill (OCP) (35 \u03bcg ethinyl estradiol\/2 mg cyproterone acetate) or metformin (1 g b.i.d.). Outcome measures were insulin resistance (total insulin area under the curve) on an oral glucose tolerance test, RBP4, and metabolic\/inflammatory markers.<\/jats:p>\n               <jats:p>RESULTS\u2014Overweight women with PCOS were more insulin resistant than control subjects, yet RBP4 levels were not different in women with PCOS versus those in control subjects (35.4 \u00b1 4.3 vs. 28.9 \u00b1 3.1 \u03bcg\/ml, P = 0.36). RBP4 correlated with cholesterol and triglycerides but not with insulin resistance. Metformin improved insulin resistance by 35%, whereas the OCP worsened insulin resistance by 33%. However, RBP4 increased nonsignificantly in both groups (43.7 \u00b1 6.3 vs. 42.6 \u00b1 5.5 \u03bcg\/ml, P = 0.92).<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014Overweight women with PCOS were more insulin resistant than control subjects, but this finding was not reflected by RBP4 levels. RBP4 correlated with lipid levels but not with insulin resistance markers. RBP4 levels did not change when insulin resistance was reduced by metformin or increased by the OCP. These data suggest that RBP4 is not a useful marker of insulin resistance in PCOS but may reflect other metabolic features of this condition.<\/jats:p>","DOI":"10.2337\/dc07-2265","type":"journal-article","created":{"date-parts":[[2008,6,7]],"date-time":"2008-06-07T00:49:14Z","timestamp":1212799754000},"page":"1427-1432","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":42,"title":["Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome"],"prefix":"10.2337","volume":"31","author":[{"given":"Samantha K.","family":"Hutchison","sequence":"first","affiliation":[{"name":"Jean Hailes Foundation Research Group, Monash University Institute of Health Services Research, Melbourne, Australia"},{"name":"Diabetes Unit, Southern Health, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryce","family":"Harrison","sequence":"additional","affiliation":[{"name":"Jean Hailes Foundation Research Group, Monash University Institute of Health Services Research, Melbourne, Australia"},{"name":"Department of Physiology, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Stepto","sequence":"additional","affiliation":[{"name":"Department of Physiology, Monash University, Melbourne, Australia"},{"name":"School of Human Movement, Recreation and Performance, Victoria University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Meyer","sequence":"additional","affiliation":[{"name":"Diabetes Unit, Southern Health, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena J.","family":"Teede","sequence":"additional","affiliation":[{"name":"Jean Hailes Foundation Research Group, Monash University Institute of Health Services Research, Melbourne, Australia"},{"name":"Diabetes Unit, Southern Health, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031302080085900_R1","doi-asserted-by":"crossref","unstructured":"Diamanti-Kandarakis E, Papavassiliou AG: Molecular mechanisms of insulin resistance in polycystic ovary syndrome Trends Mol Med\u200812; 324\u2013332, 2006","DOI":"10.1016\/j.molmed.2006.05.006"},{"key":"2022031302080085900_R2","doi-asserted-by":"crossref","unstructured":"Teede H, Hutchison SK, Zoungas S: The management of insulin resistance in polycystic ovary syndrome. Trends Endocrinol Metab\u200818:273\u2013279, 2007","DOI":"10.1016\/j.tem.2007.08.001"},{"key":"2022031302080085900_R3","doi-asserted-by":"crossref","unstructured":"Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB: Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes Nature\u2008436:356\u2013362, 2005","DOI":"10.1038\/nature03711"},{"key":"2022031302080085900_R4","doi-asserted-by":"crossref","unstructured":"Graham TE, Yang Q, Blu\u0308her M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson P-A, Smith U, Kahn BB: Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med\u2008354:2552\u20132563, 2006","DOI":"10.1056\/NEJMoa054862"},{"key":"2022031302080085900_R5","doi-asserted-by":"crossref","unstructured":"Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B: Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab\u200892:1168\u20131171, 2007","DOI":"10.1210\/jc.2006-1839"},{"key":"2022031302080085900_R6","doi-asserted-by":"crossref","unstructured":"Cho YM, Youn, B-S, Lee H, Lee N, Min, S-S, Kwak SH, Lee HK, Park KS: Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care\u200829:2457\u20132461, 2006","DOI":"10.2337\/dc06-0360"},{"key":"2022031302080085900_R7","doi-asserted-by":"crossref","unstructured":"Tan BK, Chen J, Lehnert H, Kennedy R, Randeva HS: Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocrinol Metab\u200892:2764\u20132772, 2007","DOI":"10.1210\/jc.2007-0091"},{"key":"2022031302080085900_R8","doi-asserted-by":"crossref","unstructured":"Janke J, Engeli S, Boschmann M, Adams F, Bo\u0308hnke J, Luft FC, Sharma AM: Jordan J: Retinol-binding protein 4 in human obesity. Diabetes\u200855:2805\u20132810, 2006","DOI":"10.2337\/db06-0616"},{"key":"2022031302080085900_R9","doi-asserted-by":"crossref","unstructured":"Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee, M-J, Starks T, Kern LM, Spencer HJ III, Rashidi AA, McGehee RE Jr, Fried SK, Kern PA: Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab\u200892:2590\u20132597, 2007","DOI":"10.1210\/jc.2006-0816"},{"key":"2022031302080085900_R10","doi-asserted-by":"crossref","unstructured":"Vitkova M, Klimcakova E, Kovacikova M, Valle C, Moro C, Polak J, Hanacek J, Capel F, Viguerie N, Richterova B, Bajzova M, Hejnova J, Stich V, Langin D: Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity. J Clin Endocrinol Metab\u200892:2330\u20132335, 2007","DOI":"10.1210\/jc.2006-2668"},{"key":"2022031302080085900_R11","doi-asserted-by":"crossref","unstructured":"Graham TE, Wason CJ, Blu\u0308her M, Kahn BB: Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia\u200850:814\u2013823, 2007","DOI":"10.1007\/s00125-006-0557-0"},{"key":"2022031302080085900_R12","doi-asserted-by":"crossref","unstructured":"Meyer C, McGrath BP, Teede HJ: Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care\u200830:471\u2013478, 2007","DOI":"10.2337\/dc06-0618"},{"key":"2022031302080085900_R13","doi-asserted-by":"crossref","unstructured":"Broekmans FJ, Knauff EAH, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BCJM: PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG\u2008113:1210\u20131217, 2006","DOI":"10.1111\/j.1471-0528.2006.01008.x"},{"key":"2022031302080085900_R14","doi-asserted-by":"crossref","unstructured":"Carmina E, Chu MC, Longo RA, Rini GB, Lobo RA: Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab\u200890:2545\u20132549, 2005","DOI":"10.1210\/jc.2004-2279"},{"key":"2022031302080085900_R15","doi-asserted-by":"crossref","unstructured":"Hahn S, Backhaus M, Broecker-Preuss M, Tan S, Dietz T, Kimmig R, Schmidt M, Mann K, Janssen OE: Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism. Eur J Endocrinol\u2008157:201\u2013207, 2007","DOI":"10.1530\/EJE-07-0143"},{"key":"2022031302080085900_R16","unstructured":"Lord JM, Flight IH, Norman RJ: Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome Cochrane Database Syst Rev\u2008CD003053, 2003"},{"key":"2022031302080085900_R17","doi-asserted-by":"crossref","unstructured":"Heutling D, Schulz H, Nickel I, Kleinstein J, Kaltwasser P, Westphal S, Mittermayer F, Wolzt M, Krzyzanowska K, Randeva H, Schernthaner G, Lehnert H: Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment. J Clin Endocrinol Metab\u200893:82\u201390, 2008","DOI":"10.1210\/jc.2007-0842"},{"key":"2022031302080085900_R18","doi-asserted-by":"crossref","unstructured":"Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC, Leppert PC, Myers ER, the Cooperative Multicenter Reproductive Medicine Network: Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med\u2008356:551\u2013566, 2007","DOI":"10.1056\/NEJMoa063971"},{"key":"2022031302080085900_R19","doi-asserted-by":"crossref","unstructured":"Legro RS, Kunselman AR, Dunaif A: Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med\u2008111:607\u2013613, 2001","DOI":"10.1016\/S0002-9343(01)00948-2"},{"key":"2022031302080085900_R20","doi-asserted-by":"crossref","unstructured":"Saenz A, Fernandez-Esteban I, Mataix A, Ausejo M, Roque M, Moher D: Metformin monotherapy for type 2 diabetes mellitus. Cochrane Database Syst Rev\u2008CD002966, 2005","DOI":"10.1002\/14651858.CD002966.pub3"},{"key":"2022031302080085900_R21","doi-asserted-by":"crossref","unstructured":"Ciampelli M, Leoni F, Cucinelli F, Mancuso S, Panunzi S, De Gaetano A, Lanzone A: Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients. J Clin Endocrinol Metab\u200890:1398\u20131406, 2005","DOI":"10.1210\/jc.2004-0410"},{"key":"2022031302080085900_R22","doi-asserted-by":"crossref","unstructured":"Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz A, Quon MJ, Baron AD: Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab\u200886:5457\u20135464, 2001","DOI":"10.1210\/jcem.86.11.7880"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/7\/1427\/599532\/zdc00708001427.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/7\/1427\/599532\/zdc00708001427.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T06:15:47Z","timestamp":1647152147000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/31\/7\/1427\/39073\/Retinol-Binding-Protein-4-and-Insulin-Resistance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,1]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc07-2265","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,1]]}}}